Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ribotek Biopharmaceuticals (shandong) Co., Ltd

Clinical trials sponsored by Ribotek Biopharmaceuticals (shandong) Co., Ltd, explained in plain language.

Trials to join now! 1

New drug aims to tame dangerous blood fats

Disease control Recruiting now

This study tests an experimental drug called RBD5044 in 40 adults with high triglycerides, a type of blood fat that raises heart risk. Participants receive either the drug or a placebo twice over 12 weeks. The main goal is to see if RBD5044 safely lowers triglyceride levels.

Phase: PHASE2 • Sponsor: Ribotek Biopharmaceuticals (Shandong) Co., Ltd • Aim: Disease control

Last updated May 20, 2026 11:57 UTC